Chemosensitization by 4-hydroxyphenyl retinamide-induced NF-κB inhibition in acute myeloid leukemia cells.

Cancer Chemotherapy and Pharmacology
Hui ZhangFenggui Wei

Abstract

Inherent and/or acquired multi-drug resistance might be the instigator of treatment failure for acute myeloid leukemia (AML). In the current study, we aimed to explored the chemosensitizing effect of 4-HPR on AML therapy. Luciferase reporter assays were used to test the effect of 4-HPR on transcriptional signaling pathways. The quantitative real-time polymerase chain reaction and immunoblots were used to confirm the role of 4-HPR in NF-κB inhibition, apoptosis, and drug resistance. MTT and flow cytometry assays were applied to test the drug response and chemosensitizing effect of 4-HPR with AML cell lines and primary AML samples. 4-HPR suppressed tumor necrosis factor-α- and daunorubin-induced NF-κB activation in AML cell lines. The expression of anti-apoptotic gene, BCL2, was downregulated, while expressions of pro-apoptotic genes, cIAP, XIAP, and BID, were increased after 4-HPR treatment. Immunoblots showed decreased p65-NF-κB, IκBα, and MDR1, but increased cleaved poly (ADP-ribose) polymerase and BIM. A low concentration of 4-HPR chemosensitized AML cells to daunorubin treatment in vitro. 4-HPR-induced NF-κB inhibition was the main driver of the chemosensitizing effect observed in AML cell lines and primary AML samples. Thes...Continue Reading

References

Nov 5, 1999·Journal of the National Cancer Institute·U VeronesiM B Sporn
Aug 3, 2001·Apoptosis : an International Journal on Programmed Cell Death·J M WuT C Hsieh
Nov 27, 2002·Proceedings of the National Academy of Sciences of the United States of America·Monica L GuzmanCraig T Jordan
Oct 31, 2003·Expert Opinion on Investigational Drugs·Winfred MaloneHoward Higley
Aug 6, 2004·The New England Journal of Medicine·Amy HollemanWilliam E Evans
Oct 30, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vinay K PuduvalliUNKNOWN North American Brain Tumor Consortium
Apr 2, 2005·Nature Reviews. Cancer·Chikashi Nakanishi, Masakazu Toi
May 6, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·U VeronesiG De Palo
Jul 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·UNKNOWN Children's Oncology Group (CCG 09709)Patrick C Reynolds
Jan 1, 2009·Nature Reviews. Drug Discovery·Véronique Baud, Michael Karin
Feb 20, 2009·Investigational New Drugs·Bryan J SchneiderGregory P Kalemkerian
Jul 27, 2010·Advanced Drug Delivery Reviews·Nathan Bushue, Yu-Jui Yvonne Wan
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marina Y Konopleva, Craig T Jordan
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alan BurnettBob Löwenberg
Sep 13, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Judith G VillablancaC Patrick Reynolds
Mar 21, 2013·Proceedings of the National Academy of Sciences of the United States of America·Hui ZhangKan-Kan Wang
Nov 12, 2013·Stem Cells·Monica L Guzman, John N Allan
Jan 15, 2014·Cellular and Molecular Life Sciences : CMLS·Chiara GaspariniGiorgio Zauli
Jun 3, 2014·American Journal of Respiratory Cell and Molecular Biology·Cynthia KanagarathamDanuta Radzioch
Jul 15, 2015·Pharmacology Research & Perspectives·Julie Foucquier, Mickael Guedj
Sep 17, 2015·The New England Journal of Medicine·Hartmut DöhnerClara D Bloomfield
Oct 23, 2015·Critical Reviews in Oncology/hematology·Matthieu Cornelis Johannes BosmanEdo Vellenga
Jan 26, 2016·CA: a Cancer Journal for Clinicians·Wanqing ChenJie He
Mar 14, 2017·Current Treatment Options in Oncology·Prithviraj BoseJorge E Cortes
Apr 22, 2017·Experimental Biology and Medicine·Jason P CooperMin H Kang
Aug 24, 2019·Journal of Experimental & Clinical Cancer Research : CR·Isabella OrientiAdriana Eramo

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.